A boardroom shake-up at Novo Nordisk has handed unprecedented power to its top shareholder, the Novo Nordisk Foundation, ...
Novo Nordisk, which lobbied to win Medicaid reimbursement for its obesity drug Wegovy, is fighting to keep that coverage as ...
The overhaul comes after the foundation ousted former chief executive Lars Fruergaard Jørgensen in May, blaming him for an ...
Novo Nordisk has topped Pfizer’s offer for Metsera with a bid of up to US$9 billion, seeking to secure Metsera’s obesity-drug ...
Novo Nordisk's board changes stem from disagreements with the Novo Nordisk Foundation over board composition and strategic ...
Novo Nordisk A/S ( NVO) Discusses Extraordinary General Meeting on Proposed Board Changes and Governance October 21, 2025 9:00 AM EDT ...
Novo Nordisk today announced plans to present 11 abstracts at the 76th Annual American Association for the Study of Liver ...
Further to company announcement no. 28 issued today, an Extraordinary General Meeting of Novo Nordisk A/S is called to elect ...
Novo Nordisk will hold an Extraordinary General Meeting to elect new board members due to a disagreement with the Foundation over board composition. Key board members, including Chair Helge Lund, will ...
MASH data to be presented at the 76th Annual AASLD The Liver Meeting®, 7-11 November Highlights include data from post-hoc analyses ...
Researchers from the University of Bath who uncovered undisclosed payments by Novo Nordisk have commented on the departure of several members of the company’s board.Dr Emily Rickard and Dr Piotr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback